| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |